Agenparl
Image default
Home » HUMAN MEDICINES EUROPEAN PUBLIC ASSESSMENT REPORT (EPAR): ATRIANCE, NELARABINE, PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA, DATE OF AUTHORISATION: 22/08/2007, REVISION: 24, STATUS: AUTHORISED

HUMAN MEDICINES EUROPEAN PUBLIC ASSESSMENT REPORT (EPAR): ATRIANCE, NELARABINE, PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA, DATE OF AUTHORISATION: 22/08/2007, REVISION: 24, STATUS: AUTHORISED

(AGENPARL) – LONDON (UNITED KINGDOM), sab 05 dicembre 2020 Human medicines European public assessment report (EPAR): Atriance, nelarabine, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Date of authorisation: 22/08/2007, Revision: 24, Status: Authorised

Fonte/Source: https://www.ema.europa.eu/en/medicines/human/EPAR/atriance

Post collegati

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More